Clinical Trial Update: Safety and Efficacy of Bone Marrow Derived Autologous Cells Treatment of Cerebral Palsy in Subjects Above 15 Years [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on safety and efficacy of autologous bone marrow–derived cells for cerebral palsy in subjects over 15 years, spanning Phase 1 and Phase 2;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebral Palsy Ataxic Type

Drugs mentioned

• bone marrow derived autologous cells

Snippet

Sponsor: Chaitanya Hospital, Pune | Conditions: Ataxic Infantile Cerebral Palsy | Phase 1, Phase 2 | Status: UNKNOWN